Literature DB >> 2896651

Restriction fragment length polymorphisms and an HLA-DRw52-associated split.

M Chatila1, L Luyrink, J McEleney, T Spies, J L Strominger, D N Glass.   

Abstract

The restriction fragment length polymorphism technique, employing seven restriction endonucleases, and a DR-specific repeated element probe were used to study a large panel of homozygous typing cells in order to delineate haplotypic differences within the HLA-DRw52 supertype. Most of the restriction endonucleases revealed the presence of two allelic restriction fragment length polymorphisms correlating with and splitting the HLA-DRw52 supertypic specificity. One designated A, correlated with the HLA-DRw52 typing in HLA-DR5, HLA-DR3, (non-A1, B8), and some HLA-DRw6 haplotypes. The other, designated a, correlated with the HLA-DRw52 typing in HLA-DR5, HLA-DRw8, HLA-DR3 (A1, B8), and the remaining HLA-DRw6 haplotypes. The general applicability of these findings was validated in 47 HLA-typed laboratory controls.

Mesh:

Substances:

Year:  1988        PMID: 2896651     DOI: 10.1016/0198-8859(88)90084-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  HLA-DRB3 gene alleles in Caucasian patients with Graves' disease.

Authors:  B O Boehm; P Kühnl; B J Manfras; M Chen; J C Lee; G Holzberger; S Seidl; E Schifferdecker; P M Schumm-Draeger; K H Usadel
Journal:  Clin Investig       Date:  1992-10

2.  Polymorphism of three HLA-DR3-bearing major histocompatibility complex extended haplotypes.

Authors:  D P Singal; D Green; B Reid; M D'Souza
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria.

Authors:  D P Singal; B Reid; D Green; M D'Souza; W G Bensen; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.